 | • レポートコード：MRC2-11QY11892 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は発疹のグローバル市場について調査・分析したレポートです。種類別（ルベオラ、風疹、伝染性紅斑、突発性発疹）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別発疹の競争状況、市場シェア ・世界の発疹市場：種類別市場規模 2015年-2020年（ルベオラ、風疹、伝染性紅斑、突発性発疹） ・世界の発疹市場：種類別市場規模予測 2021年-2026年（ルベオラ、風疹、伝染性紅斑、突発性発疹） ・世界の発疹市場：用途別市場規模 2015年-2020年（病院・クリニック、その他） ・世界の発疹市場：用途別市場規模予測 2021年-2026年（病院・クリニック、その他） ・北米の発疹市場分析：米国、カナダ ・ヨーロッパの発疹市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの発疹市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の発疹市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの発疹市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Manus Aktteva Biopharma、Teva Pharmaceutical Industries、CIRON Drugs & Pharmaceuticals、Iol Chemicals and Pharmaceuticals、Mikart、Ranbaxy Laboratories、Hikma、Nexgen Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
An exanthem or exanthema is a widespread rash usually occurring in children. An exanthem can be caused by toxins, drugs, or microorganisms, or can result from autoimmune disease.
Geographically, North America dominated the exanthema market and Asia Pacific is projected to have fastest growth, owing to rapidly increasing awareness levels, modernizing healthcare infrastructure and favourable government support in this region.
Market Analysis and Insights: Global Exanthema Market
The global Exanthema market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Exanthema Scope and Market Size
Exanthema market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Exanthema market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Manus Aktteva Biopharma
Teva Pharmaceutical Industries
CIRON Drugs & Pharmaceuticals
Iol Chemicals and Pharmaceuticals
Mikart
Ranbaxy Laboratories
Hikma
Nexgen Pharma
Market segment by Type, the product can be split into
Rubeola
Rubella
Erythema Infectiosum
Roseola Infantum
Market segment by Application, split into
Hospitals and Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Exanthema Revenue
1.4 Market by Type
1.4.1 Global Exanthema Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Rubeola
1.4.3 Rubella
1.4.4 Erythema Infectiosum
1.4.5 Roseola Infantum
1.5 Market by Application
1.5.1 Global Exanthema Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Exanthema Market Perspective (2015-2026)
2.2 Global Exanthema Growth Trends by Regions
2.2.1 Exanthema Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Exanthema Historic Market Share by Regions (2015-2020)
2.2.3 Exanthema Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Exanthema Market Growth Strategy
2.3.6 Primary Interviews with Key Exanthema Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Exanthema Players by Market Size
3.1.1 Global Top Exanthema Players by Revenue (2015-2020)
3.1.2 Global Exanthema Revenue Market Share by Players (2015-2020)
3.1.3 Global Exanthema Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Exanthema Market Concentration Ratio
3.2.1 Global Exanthema Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Exanthema Revenue in 2019
3.3 Exanthema Key Players Head office and Area Served
3.4 Key Players Exanthema Product Solution and Service
3.5 Date of Enter into Exanthema Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Exanthema Historic Market Size by Type (2015-2020)
4.2 Global Exanthema Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Exanthema Market Size by Application (2015-2020)
5.2 Global Exanthema Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Exanthema Market Size (2015-2020)
6.2 Exanthema Key Players in North America (2019-2020)
6.3 North America Exanthema Market Size by Type (2015-2020)
6.4 North America Exanthema Market Size by Application (2015-2020)
7 Europe
7.1 Europe Exanthema Market Size (2015-2020)
7.2 Exanthema Key Players in Europe (2019-2020)
7.3 Europe Exanthema Market Size by Type (2015-2020)
7.4 Europe Exanthema Market Size by Application (2015-2020)
8 China
8.1 China Exanthema Market Size (2015-2020)
8.2 Exanthema Key Players in China (2019-2020)
8.3 China Exanthema Market Size by Type (2015-2020)
8.4 China Exanthema Market Size by Application (2015-2020)
9 Japan
9.1 Japan Exanthema Market Size (2015-2020)
9.2 Exanthema Key Players in Japan (2019-2020)
9.3 Japan Exanthema Market Size by Type (2015-2020)
9.4 Japan Exanthema Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Exanthema Market Size (2015-2020)
10.2 Exanthema Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Exanthema Market Size by Type (2015-2020)
10.4 Southeast Asia Exanthema Market Size by Application (2015-2020)
11 India
11.1 India Exanthema Market Size (2015-2020)
11.2 Exanthema Key Players in India (2019-2020)
11.3 India Exanthema Market Size by Type (2015-2020)
11.4 India Exanthema Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Exanthema Market Size (2015-2020)
12.2 Exanthema Key Players in Central & South America (2019-2020)
12.3 Central & South America Exanthema Market Size by Type (2015-2020)
12.4 Central & South America Exanthema Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Manus Aktteva Biopharma
13.1.1 Manus Aktteva Biopharma Company Details
13.1.2 Manus Aktteva Biopharma Business Overview
13.1.3 Manus Aktteva Biopharma Exanthema Introduction
13.1.4 Manus Aktteva Biopharma Revenue in Exanthema Business (2015-2020))
13.1.5 Manus Aktteva Biopharma Recent Development
13.2 Teva Pharmaceutical Industries
13.2.1 Teva Pharmaceutical Industries Company Details
13.2.2 Teva Pharmaceutical Industries Business Overview
13.2.3 Teva Pharmaceutical Industries Exanthema Introduction
13.2.4 Teva Pharmaceutical Industries Revenue in Exanthema Business (2015-2020)
13.2.5 Teva Pharmaceutical Industries Recent Development
13.3 CIRON Drugs & Pharmaceuticals
13.3.1 CIRON Drugs & Pharmaceuticals Company Details
13.3.2 CIRON Drugs & Pharmaceuticals Business Overview
13.3.3 CIRON Drugs & Pharmaceuticals Exanthema Introduction
13.3.4 CIRON Drugs & Pharmaceuticals Revenue in Exanthema Business (2015-2020)
13.3.5 CIRON Drugs & Pharmaceuticals Recent Development
13.4 Iol Chemicals and Pharmaceuticals
13.4.1 Iol Chemicals and Pharmaceuticals Company Details
13.4.2 Iol Chemicals and Pharmaceuticals Business Overview
13.4.3 Iol Chemicals and Pharmaceuticals Exanthema Introduction
13.4.4 Iol Chemicals and Pharmaceuticals Revenue in Exanthema Business (2015-2020)
13.4.5 Iol Chemicals and Pharmaceuticals Recent Development
13.5 Mikart
13.5.1 Mikart Company Details
13.5.2 Mikart Business Overview
13.5.3 Mikart Exanthema Introduction
13.5.4 Mikart Revenue in Exanthema Business (2015-2020)
13.5.5 Mikart Recent Development
13.6 Ranbaxy Laboratories
13.6.1 Ranbaxy Laboratories Company Details
13.6.2 Ranbaxy Laboratories Business Overview
13.6.3 Ranbaxy Laboratories Exanthema Introduction
13.6.4 Ranbaxy Laboratories Revenue in Exanthema Business (2015-2020)
13.6.5 Ranbaxy Laboratories Recent Development
13.7 Hikma
13.7.1 Hikma Company Details
13.7.2 Hikma Business Overview
13.7.3 Hikma Exanthema Introduction
13.7.4 Hikma Revenue in Exanthema Business (2015-2020)
13.7.5 Hikma Recent Development
13.8 Nexgen Pharma
13.8.1 Nexgen Pharma Company Details
13.8.2 Nexgen Pharma Business Overview
13.8.3 Nexgen Pharma Exanthema Introduction
13.8.4 Nexgen Pharma Revenue in Exanthema Business (2015-2020)
13.8.5 Nexgen Pharma Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Exanthema Key Market Segments
Table 2. Key Players Covered: Ranking by Exanthema Revenue
Table 3. Ranking of Global Top Exanthema Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Exanthema Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Rubeola
Table 6. Key Players of Rubella
Table 7. Key Players of Erythema Infectiosum
Table 8. Key Players of Roseola Infantum
Table 9. Global Exanthema Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Exanthema Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Exanthema Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Exanthema Market Share by Regions (2015-2020)
Table 13. Global Exanthema Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Exanthema Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Exanthema Market Growth Strategy
Table 19. Main Points Interviewed from Key Exanthema Players
Table 20. Global Exanthema Revenue by Players (2015-2020) (Million US$)
Table 21. Global Exanthema Market Share by Players (2015-2020)
Table 22. Global Top Exanthema Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exanthema as of 2019)
Table 23. Global Exanthema by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Exanthema Product Solution and Service
Table 26. Date of Enter into Exanthema Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Exanthema Market Size by Type (2015-2020) (Million US$)
Table 29. Global Exanthema Market Size Share by Type (2015-2020)
Table 30. Global Exanthema Revenue Market Share by Type (2021-2026)
Table 31. Global Exanthema Market Size Share by Application (2015-2020)
Table 32. Global Exanthema Market Size by Application (2015-2020) (Million US$)
Table 33. Global Exanthema Market Size Share by Application (2021-2026)
Table 34. North America Key Players Exanthema Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Exanthema Market Share (2019-2020)
Table 36. North America Exanthema Market Size by Type (2015-2020) (Million US$)
Table 37. North America Exanthema Market Share by Type (2015-2020)
Table 38. North America Exanthema Market Size by Application (2015-2020) (Million US$)
Table 39. North America Exanthema Market Share by Application (2015-2020)
Table 40. Europe Key Players Exanthema Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Exanthema Market Share (2019-2020)
Table 42. Europe Exanthema Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Exanthema Market Share by Type (2015-2020)
Table 44. Europe Exanthema Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Exanthema Market Share by Application (2015-2020)
Table 46. China Key Players Exanthema Revenue (2019-2020) (Million US$)
Table 47. China Key Players Exanthema Market Share (2019-2020)
Table 48. China Exanthema Market Size by Type (2015-2020) (Million US$)
Table 49. China Exanthema Market Share by Type (2015-2020)
Table 50. China Exanthema Market Size by Application (2015-2020) (Million US$)
Table 51. China Exanthema Market Share by Application (2015-2020)
Table 52. Japan Key Players Exanthema Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Exanthema Market Share (2019-2020)
Table 54. Japan Exanthema Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Exanthema Market Share by Type (2015-2020)
Table 56. Japan Exanthema Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Exanthema Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Exanthema Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Exanthema Market Share (2019-2020)
Table 60. Southeast Asia Exanthema Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Exanthema Market Share by Type (2015-2020)
Table 62. Southeast Asia Exanthema Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Exanthema Market Share by Application (2015-2020)
Table 64. India Key Players Exanthema Revenue (2019-2020) (Million US$)
Table 65. India Key Players Exanthema Market Share (2019-2020)
Table 66. India Exanthema Market Size by Type (2015-2020) (Million US$)
Table 67. India Exanthema Market Share by Type (2015-2020)
Table 68. India Exanthema Market Size by Application (2015-2020) (Million US$)
Table 69. India Exanthema Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Exanthema Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Exanthema Market Share (2019-2020)
Table 72. Central & South America Exanthema Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Exanthema Market Share by Type (2015-2020)
Table 74. Central & South America Exanthema Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Exanthema Market Share by Application (2015-2020)
Table 76. Manus Aktteva Biopharma Company Details
Table 77. Manus Aktteva Biopharma Business Overview
Table 78. Manus Aktteva Biopharma Product
Table 79. Manus Aktteva Biopharma Revenue in Exanthema Business (2015-2020) (Million US$)
Table 80. Manus Aktteva Biopharma Recent Development
Table 81. Teva Pharmaceutical Industries Company Details
Table 82. Teva Pharmaceutical Industries Business Overview
Table 83. Teva Pharmaceutical Industries Product
Table 84. Teva Pharmaceutical Industries Revenue in Exanthema Business (2015-2020) (Million US$)
Table 85. Teva Pharmaceutical Industries Recent Development
Table 86. CIRON Drugs & Pharmaceuticals Company Details
Table 87. CIRON Drugs & Pharmaceuticals Business Overview
Table 88. CIRON Drugs & Pharmaceuticals Product
Table 89. CIRON Drugs & Pharmaceuticals Revenue in Exanthema Business (2015-2020) (Million US$)
Table 90. CIRON Drugs & Pharmaceuticals Recent Development
Table 91. Iol Chemicals and Pharmaceuticals Company Details
Table 92. Iol Chemicals and Pharmaceuticals Business Overview
Table 93. Iol Chemicals and Pharmaceuticals Product
Table 94. Iol Chemicals and Pharmaceuticals Revenue in Exanthema Business (2015-2020) (Million US$)
Table 95. Iol Chemicals and Pharmaceuticals Recent Development
Table 96. Mikart Company Details
Table 97. Mikart Business Overview
Table 98. Mikart Product
Table 99. Mikart Revenue in Exanthema Business (2015-2020) (Million US$)
Table 100. Mikart Recent Development
Table 101. Ranbaxy Laboratories Company Details
Table 102. Ranbaxy Laboratories Business Overview
Table 103. Ranbaxy Laboratories Product
Table 104. Ranbaxy Laboratories Revenue in Exanthema Business (2015-2020) (Million US$)
Table 105. Ranbaxy Laboratories Recent Development
Table 106. Hikma Company Details
Table 107. Hikma Business Overview
Table 108. Hikma Product
Table 109. Hikma Revenue in Exanthema Business (2015-2020) (Million US$)
Table 110. Hikma Recent Development
Table 111. Nexgen Pharma Business Overview
Table 112. Nexgen Pharma Product
Table 113. Nexgen Pharma Company Details
Table 114. Nexgen Pharma Revenue in Exanthema Business (2015-2020) (Million US$)
Table 115. Nexgen Pharma Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exanthema Market Share by Type: 2020 VS 2026
Figure 2. Rubeola Features
Figure 3. Rubella Features
Figure 4. Erythema Infectiosum Features
Figure 5. Roseola Infantum Features
Figure 6. Global Exanthema Market Share by Application: 2020 VS 2026
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Exanthema Report Years Considered
Figure 10. Global Exanthema Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Exanthema Market Share by Regions: 2020 VS 2026
Figure 12. Global Exanthema Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Exanthema Market Share by Players in 2019
Figure 15. Global Top Exanthema Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exanthema as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Exanthema Revenue in 2019
Figure 17. North America Exanthema Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Exanthema Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Exanthema Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Exanthema Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Exanthema Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Exanthema Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Exanthema Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
持続性顔面紅斑治療の世界市場（～2026年） Facial erythema is a very common reason for consulting a dermatologist. While often a manifestation of a benign condition, in some cases facial erythema may be the first sign of a more serious disorder and specific diagnostic tests are needed to rule out these diseases. Market Analysis and Insights:…- 風疹診断検査の世界市場（～2026年） Rubella infection generally affects children and adults. This infection has a serious effect on pregnant women and may result in fetal death or congenital defects. Geographically, the entire rubella diagnostic testing market is classified into North America, Europe, Asia Pacific, Latin America and M…
- 化学療法薬誘発性肢端紅斑（手足症候群）治療の世界市場（～2026年） Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear afte…
- 移動病院の世界市場（～2026年） Mobile hospitals are the medical centers or mini hospitals with all the facilities and fully equipped that can be moved from one place and settle in new place and situation smoothly. Mobile hospitals provide medical services to the patient or the injured person in the critical conditions such as nat…
- マイクロホスピタルの世界市場（～2026年） Micro-hospitals are small-scale inpatient facilities on two to three-story buildings built on 20,000 to 50,000-square foot spaces that offer a wide range of medical services in a small, neighborhood setting. They run 24/7, all year long, and commonly have between eight and 10 beds where patients can…